| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967844 | Vaccine | 2012 | 10 Pages |
Abstract
⺠SeVRSV, a recombinant Sendai virus expressing RSV F, was tested in AGM. ⺠SeVRSV elicited antibody responses against SeV and RSV. ⺠SeVRSV fully protected AGM from lower respiratory tract RSV infection. ⺠SeVRSV caused no clinically relevant adverse events. ⺠SeVRSV is an attractive RSV vaccine candidate.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Bart G. Jones, Robert E. Sealy, Rajeev Rudraraju, Vicki L. Traina-Dorge, Brad Finneyfrock, Anthony Cook, Toru Takimoto, Allen Portner, Julia L. Hurwitz,